| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/29/2007 | US7223759 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains |
| 05/29/2007 | US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 05/29/2007 | US7223756 Treatment of autoimmune diseases, transplant rejection and rheumatoid arthritis with a quinazoline 4-substituted by a methylenedioxyphenyl group linked to the ring by an ether, methyl, sulfide, sulfoxide or sulfone, e.g., 6-methoxy-4-(2,3-methylenedioxyphenoxy)-7-(3-pyrrolidin-1-ylpropoxy)quinazoline, |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia |
| 05/24/2007 | WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058305A1 Process for production of cinnamamide derivative |
| 05/24/2007 | WO2007058304A1 Salts of cynnamide compound or solvates thereof |
| 05/24/2007 | WO2007057775A1 Spiropiperidine derivatives |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2007057265A2 Triazine compounds comprising substituents containing amino groups and carboxyl groups |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 05/24/2007 | WO2006042150A8 Diaminoalkane aspartic protease inhibitors |
| 05/24/2007 | US20070117850 substituted or unsubstituted 2-pyridyl moiety and a pyrozole ring substituted at 4 position with pyridine ring; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 05/24/2007 | US20070117847 N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists |
| 05/24/2007 | US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117820 1-([3-Chloro-5-trifluoromethylpyridinyl-2-yl]piperidin-4-yl)-3-(1-methyl-isoquinolin--5-yl)-urea hydrochloride; capsaicin receptor antagonist; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, neuralgia, migraine, neuropathies, diabetic neuropathy |
| 05/24/2007 | US20070117818 Pyrimidinone compounds useful as kinase inhibitors |
| 05/24/2007 | US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
| 05/24/2007 | US20070117806 Neutrophilia inhibitor |
| 05/24/2007 | US20070117795 Methods and compositions of novel triazine compounds |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
| 05/24/2007 | CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | CA2628047A1 Process for production of cinnamide derivative |
| 05/23/2007 | EP1787989A1 Triazine derivatives containing amino and carboxylic acic group |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1787982A2 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds |
| 05/23/2007 | EP1786809A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 05/23/2007 | EP1786803A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786802A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786801A1 Cytokine inhibitors |
| 05/23/2007 | EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues |
| 05/23/2007 | EP1786799A1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
| 05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |
| 05/23/2007 | EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 05/23/2007 | EP1786775A1 Dimeric piperidine derivates |
| 05/23/2007 | EP1786773A1 Isoindolin-1-one derivatives |
| 05/23/2007 | EP1786475A2 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 05/23/2007 | EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/23/2007 | EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1370550B1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP1238974B1 Heterocycle derivatives and drugs |
| 05/23/2007 | EP1140203B1 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2007 | CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/23/2007 | CN1968946A Benzimidazolone carboxylic acid derivatives |
| 05/23/2007 | CN1968945A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 05/23/2007 | CN1968937A Pyrimidin-4-one derivatives and their use as P38 kinase modulators |
| 05/23/2007 | CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 05/23/2007 | CN1968928A Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 05/23/2007 | CN1968695A Compositions comprising immunomodulatory compounds for the treatment and control of myelodysplastic syndromes and using methods |
| 05/23/2007 | CN1966500A Quinoxaline derivative, preparation method and uses |
| 05/23/2007 | CN1317277C Benzofuran derivatives and their use as antibacterial agents |
| 05/23/2007 | CN1317276C Indolylpiperidine compound and preparation process and use thereof |
| 05/23/2007 | CN1317275C Sulfoxide compound and complex of acetone, and production method thereof |
| 05/23/2007 | CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 05/22/2007 | US7220862 Calcitonin gene related peptide receptor antagonists |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220763 Indole-type derivatives as inhibitors of p38 kinase |
| 05/22/2007 | US7220762 Methods for stabilizing benzimidazole compounds |
| 05/22/2007 | US7220761 Compounds and methods for controlling fungi, bacteria and insects |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220736 Pyrimidine compounds |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2281892C Processes for preparing pesticidal intermediates |
| 05/22/2007 | CA2275353C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
| 05/22/2007 | CA2212200C Novel inhibitors of .beta.-glucuronidase |
| 05/18/2007 | WO2007056330A1 Benzimidazole derivatives as gyrase inhibitors |
| 05/18/2007 | WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators |
| 05/18/2007 | WO2007056091A2 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof |
| 05/18/2007 | WO2007056046A1 P2x7 receptor antagonists and methods of use |
| 05/18/2007 | WO2007055423A1 Process for production of 2-(4-methyl-2-phenylpiperazin- 1-yl)pyridine-3-methanol |